Gastroenterology CE Activities

Gastroenterology blog

View Details

6 Ways to Help You Choose the Right Initial Therapy for Your Patient with Ulcerative Colitis

Choosing the correct first therapy for your patients with ulcerative colitis (UC) can be tricky, but it is important because it gives them the best chance at a better life with UC. Getting it right early increases their odds of remission and reduces their risk of progression, hospitalization, and colectomy. Here are 6 ways to help get it right the first time.
View Details

These 3 Tools Will Change the Way You Manage IBD in Your Patients

Over the past couple of years, several clinical decision support tools (CDSTs) have emerged to more effectively risk stratify patients and one actually predicts their response to certain biologics before they even start them.

RMEI Presentations

When the Patient Voice is Heard in Education, Does the Clinican Listen? Dual Track Patient/Provider Education in IBD Incorporating Patients as Learners and Faculty

The Gastroenterology Learner Pathway in IBD: An Outcomes-Based Iterative Approach to IBD Education Using Advanced Analytics and Predictive Modeling to Sustain Behavioral Change

LATEST Gastroentrology ARTICLES

RSS Latest Gastroentrology Articles
  • Lumasiran, Isolated Kidney Transplantation, and Continued Vigilance March 14, 2024
    Although lumasiran targets glycolate oxidase and decreases hepatic oxalate synthesis, systemic oxalate release continues after single-organ kidney transplantation, requiring close follow-up with rigorous hyperhydration.
    Justine Bacchetta, Stéphanie Clavé, Peggy Perrin, Sandrine Lemoine, Anne-Laure Sellier-Leclerc, Lisa J. Deesker
  • Next-Generation Multitarget Stool DNA Test for Colorectal Cancer Screening March 14, 2024
    In adults undergoing screening colonoscopy, a next-generation multitarget stool DNA test had higher sensitivity for colorectal cancer and advanced precancerous lesions than a fecal immunochemical test but lower specificity.
    Thomas F. Imperiale, Kyle Porter, Julia Zella, Zubin D. Gagrat, Marilyn C. Olson, Sandi Statz, Jorge Garces, Philip T. Lavin, Humberto Aguilar, Don Brinberg, Charles Berkelhammer, John B. Kisiel, Paul J. Limburg, the BLUE-C Study Investigators
  • Improving Noninvasive Colorectal Cancer Screening March 14, 2024
    Noninvasive colorectal cancer screening commenced historically with the use of guaiac-based tests that require the addition of hydrogen peroxide to oxidize the presence of substances such as blood in stool. Large, randomized, controlled trials of these tests in a screened population showed the detection of earlier-stage cancers that could be...
    John M. Carethers

RMEI LIGHTNING TALKS

View Details

4 Years, 16 Live & Online Activities, 6000+ Clinicians: What we've learned so far

RMEI has released pairings of live and online programs approximately twice per year since 2016 grouped into “phases” which share clinical areas of focus and are based on findings from the previous phase of education. In total, 16 activities have launched to date with 4 activities currently live. The purpose of this analysis is to better understand the impact of multi-year iterative education on a clinical audience. Presented at: Society for Academic CME (SACME), virtual, February 2021; Accreditation Council for Continuing Medical Education (ACCME), virtual, April 2021.
View Details

Effectiveness of 5-year IBD Provider Online Educational Intervention Program

There is considerable practice variability among providers caring for inflammatory bowel disease (IBD) patients. Limited data exists on the effectiveness of educational interventions targeting IBD providers to address these gaps. We report outcomes for a 5-year provider education training program which culminated in an enduring online education resource and clinical decision support tool.